RE: Anyone have any good news?15 Apr 2024 21:36
I agree entirely re accountability.
I'm a long term TEK shareholder (but that's another story) and I felt that BELL was one of two companies that had global potential. Perhaps there were early warning signs with the prolonged delays when they were seeking FDA approval for X-PLOR but once secured with some money in the bank from their float, I thought it would be a simple matter of selling their product and being paid within a certain period of invoicing, or even using invoice discounting if cash flow was tight. After all, COVID had increased their potential market massively.
They seemed to have the orders, so why couldn't they convert them into cash? What has gone wrong?
I personally think those at the top should step aside, be content with the money that they've earned to date and let others who are better qualified for the task in hand, take the company forward.